Neurologist focused on Neuromuscular disorders as well as functional test of central and peripheral nerve system, including Intraoperative Monitoring (IOM) of evoked potentials. Dr. Martínez-Piñeiro obtained the “Río Hortega” grant by the Instituto de Salud Carlos III (Spanish Health Ministry).

She followed different IOM observerships at Hyman-Newman Institute of Neurology and Neurosurgery of St.Luke’s Roosevelt Hospital in New York, Intraoperative Neurophysiology Unit of Bellvitge University Hospital and Istituto Clinico Humanitas (Milano). From 2014, she has implemented a clinical and training IOM program at University Hospital Germans Trias i Pujol (HUGTiP, Barcelona).

Chief of the Neuromuscular and Electrodiagnostic Unit and Chief Intraoperative Monitoring Unit of HUGTiP. Her clinical research has focused on the application of electrodiagnostic techniques in neurovascular pathology. She has obtained competitive grants from La Marató TV3 Foundation, La Caixa Foundation with the research project: “New predictive biomarkers of functional recovery prior to the endovascular treatment of acute ischemic stroke. PROMISE (somatosensory evoked POtEntials MonItoring during acute ischemic StrokE) Study” (ClinicalTrials.gov: NCT04099615).

She is also the inventor of the patent “Prediction of the outcome of endovascular treatment in acute ischemic stroke patients” (NºPCT/EP2018/053899, no.:EP17382078.8). From an academic perspective, she has participated as speaker at national and international conferences and she cooperates with post-doctoral programs related to IOM and electrodiagnostic of Universitat de Barcelona and Universitat de Girona.

Internationally renowned Key Opinion Leader in stroke. Dr. Dávalos leads the Neurovascular Unit at the HUGTiP, considered an outstanding group in neurovascular research and acute stroke treatment, both in national and international scientific activities.

He maintains scientific collaborations with the Stroke Center at the UPMC (Pittsburgh, PA) and the HERMES Trialists Network on the primary topic of this project: Mechanical Thrombectomy in Acute Ischemic Stroke. His clinical research has focused on the acute phase of stroke, particularly on the mechanisms associated with neurological deterioration, hemorrhagic transformation and brain edema, and in reperfusion therapies.

Dr. Davalos has been principal investigator or on the steering committee in a number of drug trials on acute stroke such as the SITS-MOST, DIAS & DIAS-2, DIAS-3, ECASS II and ECASS III on thrombolytic therapy, STAR on mechanical thrombectomy, and SAINT I & II and ICTUS on neuroprotection. He is co-PI of REVASCAT trial, creating a turning point in stroke therapy and establishing a level A of evidence of the clinical benefit of mechanical thrombectomy in acute ischemic stroke with health, social and economic consequences.

Jaume Coll Cantí (Founder, Scientific Advisory Board): Neurologist. +30 yrs. in neuromuscular disorders and electrodiagnostic.

Expert in electromyography diagnostic techniques. +30 publications (Q1 & Q2). He created and lead the Neuromuscular Disease & functional diagnostic of nervous system from Hospital Germans TriasI Pujol. Associated Professor, Neurology, UAB. President of the Catalan Society of Neurology (2004-2006).